Synthesis of bio-stabilized silver nanoparticles using Roccella montagnei, their anticandidal capacities & potential

Shweta Bharti1, Balwant Singh2, Sanket Kumar3

  • 1Department of Environmental Microbiology, Babasaheb Bhimrao Ambedkar University, Lucknow, Lucknow, India.

Insights

This study biosynthesized silver nanoparticles (AgNPs) from Roccella montagnei lichen to combat drug-resistant Candida albicans. The eco-friendly Rm-AgNPs effectively inhibited fungal growth and virulence factors with low cytotoxicity.

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Mycology

Background:

  • Invasive mycoses are primarily caused by Candida species, with drug-resistant strains posing a critical global health threat.
  • WHO identifies drug-resistant Candida albicans as a priority pathogen, necessitating novel therapeutic strategies.
  • Lichens, like Roccella montagnei, possess unique phytochemicals with potential medicinal properties, including antifungal activity.

Purpose of the Study:

  • To biosynthesize silver nanoparticles (Rm-AgNPs) using Roccella montagnei lichen extract.
  • To evaluate the anticandidal efficacy of Rm-AgNPs against Fluconazole-resistant Candida albicans NBC099.
  • To investigate the mechanism of action and safety profile of Rm-AgNPs.

Main Methods:

  • Hydro-alcoholic extract of Roccella montagnei was used for the green synthesis of silver nanoparticles (Rm-AgNPs).
  • Characterization of Rm-AgNPs using UV-Vis Spectroscopy, FTIR, SEM, TEM, Zetasizer, and XRD.
  • Antifungal activity, virulence factor inhibition, apoptosis induction, and cytotoxicity assays were performed.

Main Results:

  • Characterization confirmed the formation of spherical, stable Rm-AgNPs (10-50 nm) with a face-centered cubic structure.
  • Rm-AgNPs exhibited potent inhibition of Fluconazole-resistant C. albicans NBC099 with a minimum inhibitory concentration (MIC) ≤ 15 µg/mL.
  • Rm-AgNPs significantly reduced virulence factors (hyphal formation, biofilm production, enzyme activities) and induced apoptosis via oxidative stress, with negligible cytotoxicity.

Conclusions:

  • Biosynthesis of Roccella montagnei-derived silver nanoparticles (Rm-AgNPs) offers a promising, eco-friendly anticandidal agent.
  • Rm-AgNPs demonstrate significant efficacy against drug-resistant Candida albicans by inhibiting growth and virulence factors.
  • Rm-AgNPs represent a potential alternative therapeutic strategy to enhance existing antifungal treatments with a favorable safety profile.